MK-8521

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes MellitusType II Diabetes Mellitus

Phase 1

Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)

CompletedNCT01982630

Merck Sharp & Dohme LLCDiabetes Mellitus

Start: 2013-11-07End: 2014-10-03Updated: 2022-03-08

Phase 2

A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)

TerminatedNCT02492763

Merck Sharp & Dohme LLCType II Diabetes Mellitus

Start: 2015-07-27End: 2017-04-18Updated: 2018-09-10